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sessed in a region without visible intramuscular fat (T2 lean  muscle ) 
and across the complete CSA (T2 muscle ). Furthermore,  1 H-MR 
spectroscopy was performed to evaluate the relative lipid con-
tent of the quadriceps muscles. These measurements were re-
peated 5 months later in the surviving 8 HFD and 14 CD rats. 
 Results: HFD rats revealed significantly decreased CSA and 
CSA per body weight (BW) as well as prolonged T2 relaxation 
times of muscle. A higher weight gain (upper tertile during the 
first 6 months of diet in CD rats) resulted in a significant change 
of T2 muscle , but had no relevant impact on CSA. Advancing age 
up to 21 months led to significantly decreased BW, CSA and 
CSA/BW, significantly prolonged T2 muscle and T2 lean muscle and 
enlarged lipid content in the quadriceps muscle.  Conclusions: 
In an experimental setting a chronically fat-enriched diet was 
shown to have a relevant and age-associated influence on 
both muscle quantity and quality. By translational means the 
employed MR techniques give rise to the possibility of an ear-
ly detection and noninvasive quantification of sarcopenia in 
humans, which is highly relevant for the field of geriatrics. 
 © 2014 S. Karger AG, Basel 
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 Abstract 
 Background: Knowledge about the molecular pathomecha-
nisms of sarcopenia is still sparse, especially with regard to nu-
tritional risk factors and the subtype of sarcopenic obesity.  Ob-
jective: The aim of this study was to characterize diet-induced 
and age-related changes on the quality and quantity of the 
quadriceps muscle in a rat model of sarcopenia by different 
magnetic resonance (MR) techniques.  Methods: A total of 36 
6-month-old male Sprague-Dawley rats were randomly subdi-
vided into 2 groups and received either a high-fat diet (HFD) 
or a control diet (CD). At the age of 16 months, 15 HFD and 18 
CD rats underwent MR at 1.5 T. T1-weighted images as well as 
T2 relaxation time maps were acquired perpendicular to the 
long axis of the quadriceps muscles. Maximum cross-sectional 
area (CSA) of the quadriceps muscle was measured on T1-
weighted images, and T2 relaxation times of muscle were as-
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 Introduction 
 Sarcopenia denotes an excessive decline of skeletal 
muscle mass and strength with advancing age  [1–4] . Be-
ing one of the major causes of disability and frailty in the 
elderly, sarcopenia is a critical issue in an aging society 
and is, therefore, of major concern in contemporary ge-
riatrics.
 Many different underlying causes for sarcopenia have 
been described in the literature, ranging from disuse at-
rophy and nutritional imbalances to neurodegenerative 
diseases  [5] . Inflammation and excess of adipocytokines 
evoked by obesity were identified as risk factors for the 
loss of muscle mass in the last years  [6] . Furthermore, it 
has been speculated that a surplus of dietary fatty acids 
could also induce sarcopenia by lipotoxic effects even in 
the absence of obesity. Thereby, direct induction of apop-
tosis, autophagy and proteolysis in the myotubes are pro-
posed mechanisms  [7] . Furthermore, fatty acids may also 
interfere with the glucose-dependent PKB/Akt signaling 
and the energy-sensing AMPK pathways, leading to de-
regulation of mitochondrial biogenesis and protein syn-
thesis  [8] . Taken together, diets with a high amount of 
fatty acids appear to be important for the development 
and progression of an excessive loss of muscle mass.
 Among other parameters of physiologically relevant 
muscular changes in sarcopenia, muscle loss is primarily 
monitored by the measurement of the muscle volume or 
maximum cross-sectional area (CSA) in magnetic reso-
nance (MR) images. In a human study the CSA of the 
thighs exhibited a good correlation with muscle strength 
 [9] . Furthermore, the CSA of the quadriceps muscle of 
healthy and mildly and severely sarcopenic men differed 
significantly from each other  [10] . Nonetheless, it has 
been stated that the decline of muscle strength is under-
estimated – and therefore not sufficiently covered – by 
measuring the CSA of a muscle  [11] . This fact underlines 
the necessity for other parameters of muscle quality in 
studying and diagnosing sarcopenia.
 MR imaging (MRI) and spectroscopy (MRS) have 
been proposed as noninvasive methods to describe age-
related changes of body composition and to quantify 
body fat distribution  [12–14] . In particular, intramyocel-
lular lipid (IMCL) content has been studied as an energy 
storage within the muscle and in relation to insulin sen-
sitivity  [15–19] . Up to now, most MR-based studies fo-
cused on age-associated changes, obesity or diet-induced 
changes in cross-sectional studies  [12, 18–23] . Analysis of 
the T2 relaxation time and the lipid fraction was per-
formed in order to reveal potential nutritional lipotoxic 
effects that could play a role in decreasing muscle volume, 
as recently shown in a pilot study  [8] .
 Against this background, the aim of the present study 
was to assess diet-induced effects on muscle quantity and 
quality during aging with MRI and MRS in a rodent mod-
el, employing a species with a relatively short life span. 
For this purpose we have chosen a rat model in a con-
trolled experimental setting as it has several advantages 
compared with a similar study in humans: the dietary 
concept can be strictly followed, the influencing factors 
can be more clearly defined, the comparison with a con-
trol group is much easier and observation along a consid-
erable fraction of lifetime is possible.
 Materials and Methods 
 Animals and Dietary Procedure 
 A total of 36 male Sprague-Dawley rats were purchased (Charles 
River Laboratories, Sulzfeld, Germany) at the age of 6 months and 
included in the study without further selection or conditioning. In 
the first 6 months of life all animals got standardized species-ap-
propriate husbandry.
 The rats were subdivided into 2 groups receiving either a high-
fat diet (HFD, n = 18, 43 energy percent of neutral fat, based on 
lard and corn oil) or a control diet (CD, n = 18, 25 energy percent 
of neutral fat; Altromin, Lage, Germany). The HFD contains ex-
actly double the amount of each fatty acid species as the CD. For 
partial compensation the polysaccharides were reduced by 37%, 
leading to an approximately 14% surplus of metabolizable energy 
in the HFD. The concentration of all other components including 
disaccharides and amino acids were identical in both chows. All 
rats were given ad libitum access to water and food and were 
housed in groups of 3 rats per cage at a constant room temperature 
of 20  °  C and on a 12-hour light-dark cycle until the end of the ex-
periment.
 MRI and MRS examinations were performed at the age of 16 
and 21 months with an identical protocol for all animals.
 All animal procedures were approved by the local animal rights 
committee and were in compliance with the German law on ani-
mal protection.
 MR Examination 
 The animals were anesthetized by intraperitoneal injection of 
pentobarbital (Narcoren ® , Merial, Hallbergmoos, Germany), oxy-
gen was delivered via a mask during the MR examination and the 
animals were covered with a blanket to avoid cooling.
 MRI and  1 H-MRS were performed on a 1.5-tesla clinical scan-
ner (Magnetom Avanto; Siemens Healthcare, Erlangen, Germany) 
using an 8-channel array coil designed for human knee examina-
tions. The rats were examined in prone position with the hind 
limbs extended backwards and T1-weighted spin echo (SE) se-
quences were applied to image the quadriceps muscles of both 
hind limbs (see  fig. 1 ). Based on sagittal images ( fig. 1 b), ‘coronal’ 
images along the long axis of the quadriceps muscle ( fig. 1 d) and 
‘transverse’ images perpendicular to the long axis of the quadriceps 
muscle ( fig. 1 c) were acquired (repetition time, TR: 450 ms, echo 
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time, TE: 11 ms, voxel size: 0.4 × 0.4 × 2.0 mm 3 , 21 slices, slice gap: 
0.2 mm). A multiecho SE sequence (TR: 2,000 ms) consisting of 12 
echoes (TE: 14–169 ms, voxel size: 0.4 × 0.4 × 2.0 mm 3 ) was also 
applied perpendicular to the long axis of the quadriceps muscles 
and color-coded T2 maps were calculated by an algorithm based 
on monoexponential fitting ( fig. 2 ).
 1 H single voxel MRS was performed using a point-resolved 
spectroscopy sequence (PRESS) technique with a TR of 1,500 ms, 
a TE of 30 ms, 192 averages, and water suppression. Voxels with a 
constant size of 12 × 6 × 7 mm 3 were positioned in the right and 
left quadriceps muscle. Additional spectra without water suppres-
sion were recorded from the same volumes (single scan) for fat 
signal quantification, using water as an internal reference.
 Assessment of Biomarkers by MRI and MRS 
 The CSA of the quadriceps muscle was measured for both hind 
limbs using T1-weighted SE images orientated exactly perpendic-
ular to the long axis of the muscle. As strictly symmetrical position-
ing of both hind limbs was not possible in all rats, ‘truly perpen-
dicular’ transverse slices were therefore reconstructed from the 
original transverse slices for each hind limb separately. Maximum 
CSA was then taken from the slice with the largest CSA. The re-
producibility of this method was determined in a pilot study with 
1 rat that was measured 3 times in a row – including repositioning 
of the animal between single measurements. Each MR data set was 
evaluated 5 times, resulting in 15 results for CSA.
 T2 relaxation times of ‘lean muscle’ (T2 lean muscle ) were assessed 
in circular regions of interest (ROIs) within the quadriceps muscle, 
avoiding regions of visible intramuscular fat. In addition to these 
values representing lean musculature only, an average T2 relax-
ation time (T2 muscle ) was also evaluated for an area comprising the 
entire CSA (see  fig. 2 ). Both contours were documented to allow 
comparable positioning in the follow-up examination at the age of 
21 months ( fig. 2 ).
 MR spectra were postprocessed using the software package of-
fered by the vendor. Processing included subtraction of the water 
signal (when applicable), Fourier transformation, Hanning filter-
ing with a width of 700 ms, zero filling from a measured vector 
length of 1,024 to a length of 2,048, baseline correction (6th order 
polynomial), curve fitting, and manual phase correction for all 
spectra. Relative lipid content was calculated as ‘lipid fraction’ = 
[MRS lipids /(MRS lipids + MRS water )] × 100, with MRS water being the 
area under the water signal in the spectrum recorded without wa-
ter suppression, and MRS lipids as the integral signal taking into ac-
count all lipid signal contributions between 0.9 and 1.6 ppm and 
between 1.9 and 2.6 ppm.
 Statistical Analysis 
 Statistical analysis was performed using SPSS 21 (IBM SPSS 
Statistics, Armonk, N.Y., USA). Kaplan-Meier survival curves 
were generated for HFD and CD rats, and the log-rank test was 
applied to compare the survival in both dietary groups. For all MRI 
and MRS data (CSA, T2 relaxation times and lipid fraction), results 
of the right and left leg were averaged. All data are given as mean ± 
standard deviation within 1 group or subgroup related to age and/
or diet. Reproducibility of CSA measurements was estimated by 
calculation of the variation coefficient: (standard deviation/mean 
value) × 100.
 To assess diet-induced changes at the age of 16 months, two-
sided unpaired t testing was applied if normal distribution of data 
was confirmed by the Kolmogorov-Smirnov test; Levene’s test was 
used to test the homogeneity of variances. A 2 × 2 mixed-design 
ANOVA was used to analyze the influence of diet and age in those 
rats that survived until the age of 21 months; age served as the 
within-subject factor and diet as the between-subject factor. Dif-
ferences with p < 0.05 were regarded as statistically significant for 
all tests.
 Results 
 Up to the age of 16 months – the time of the first MR 
examination – 3 of 18 HFD rats died ( fig. 3 ). Another 3 
HFD animals died before the second MR examination at 
the age of 21 months. An additional 4 rats had to be sac-
rificed due to large neoplasms or worsening general 
health condition according to good animal care practice 
(UFAW Handbook on the Care and Management of Lab-
oratory Animals, 2010). From the CD group, 2 animals 
died and another 2 had to be sacrificed before the age of 
21 months ( fig. 3 ). Thus, MR was performed at the age of 
16 months in 15 HFD and 18 CD rats; the identical MR 
protocol could be repeated 5 months later in 8 HFD and 
14 CD rats. The log-rank test revealed a significantly lon-
ger survival of CD rats compared with HFD rats (p  = 
0.041).
 The variation coefficient for the assessment of CSA – 
evaluated in 15 consecutive measurements – was 1.77%, 
indicating very good reproducibility of this method.
 Fig. 1. PRESS spectrum of the right quadriceps muscle in an HFD 
rat at the age of 21 months ( a ). Positioning of the voxel in sagittal 
( b ), transverse ( c ) and coronal ( d ) orientation within the right 
quadriceps muscle. 
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 At the age of 16 months the CSA of the quadriceps 
muscle was significantly smaller in HFD than in CD rats, 
while body weight (BW) was similar in both groups 
 ( table 1 ). HFD rats demonstrated prolonged T2 lean muscle 
compared with CD rats.
 In order to reveal the effects of BW on muscle param-
eters the rats were grouped based on an AUC analysis of 
the weight gain during the first 6 months of diet. With 
the upper tertile of weight gain in the CD rats arbitrarily 
set as threshold, 6 of 18 CD and 9 of 15 HFD rats were 
classified into the higher weight group ( fig. 4 ). As ex-
pected, the BW of upper tertile-weighted HFD and CD 
rats did not differ significantly from each other, and nor-
mal-weight HFD and CD rats showed quite similar BW 
as well. The CSA of quadriceps muscles was very similar 
in heavier and normal-weight CD rats, but significantly 
smaller in normal HFD when compared with normal 
CD rats. CSA/BW was significantly reduced in all heavi-
er compared to all normal-weight rats, but also in heavi-
er versus normal CD rats. T2 muscle – but not T2 lean muscle  – 
was significantly longer in heavier compared with nor-
mal-weight rats. Despite missing statistically significant 
differences between all subgroups ( fig.  4 ), there was a 
general trend towards longer T2 relaxation time of the 
muscle in HFD than in CD rats and also in heavier com-
pared with normal-weight rats. The lipid content was 
very similar in all subgroups – except for a somewhat 
lower lipid content in normal-weight CD rats.
 Longitudinal results were available in 8 HFD and 14 CD 
rats that survived until the age of 21 months.  Figure 2 
shows exemplary T2 maps of an HFD and a CD rat – both 
0
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 Fig. 3. Kaplan-Meier survival curve for 18 HFD and 18 CD rats. 
 Fig. 2. Longitudinal results of an HFD and a CD rat. T1-weighted 
image of an HFD ( a ) and CD rat ( d ) at the age of 16 months as well 
as color-coded T2 maps of an HFD rat at 16 ( b ) and 21 ( c ) months 
and a CD rat at 16 ( e ) and 21 ( f ) months. Blue indicates short, green 
longer, and red very long T2 relaxation time. The white contour in 
 a marks the CSA of the right quadriceps muscle and the ROI for 
T2 muscle in  b ; the circular ROI for evaluation of T2 lean muscle is also 
shown in  b and  c . 
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at the age of 16 and 21 months. Smaller CSA and CSA/BW, 
prolonged T2 muscle and T2 lean muscle and increased lipids in 
HFD compared with CD rats were also found in the col-
lective of the ‘survivors’ – at the age of 16 as well as at the 
age of 21 months ( fig. 5 ). A 2 × 2 mixed-design ANOVA 
revealed no interaction between age and diet, but several 
significant effects of age or diet alone ( table 2 ). BW, CSA, 
CSA/BW and T2 relaxation times, as well as lipid content, 
were significantly influenced by age. Diet had a significant 
influence on CSA, CSA/BW and T2 relaxation times.
 Table 1.  Diet-induced effects on 16-month-old rats
HFD 
(n = 15)
CD 
(n = 18)
p
BW, g 783±64 786±67 0.882
CSA, cm2 1.70±0.18 1.83±0.14 0.030
CSA/BW, cm2/kg 2.18±0.23 2.34±0.24 0.065
T2muscle, ms 33.1±1.7 32.2±0.7 0.066
T2lean muscle, ms 32.5±0.9 31.8±0.6 0.007
Lipid fraction 1.33±0.27 1.20±0.35 0.288
 p = p value (t test).
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(n = 6)
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(n = 6)
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(n = 12)
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(n = 9)
1.38 ± 0.29
(n = 6)
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f
Fig. 4. Higher weight gain (upper tertile during the first 6 months 
of diet in CD rats)  – heavy vs. normal weight – in 16-month-old 
HFD and CD rats. Influence on BW ( a ), CSA of the quadriceps 
muscle ( b ), CSA/BW ( c ), T2 relaxation time across the whole CSA 
of the quadriceps muscle (T2 muscle ;  d ), T2 relaxation time of the 
lean quadriceps muscle (T2 lean muscle ) in a region without visible fat 
( e ) and lipid fraction ( f ), based on  1 H single voxel spectroscopy. 
Large (horizontal or vertical) arrows denote statistically significant 
differences between groups (HFD vs. CD or heavy vs. normal-
weight rats); small arrows denote statistically significant differenc-
es between subgroups.
 Table 2.  Age- and diet-induced effects on 8 HFD and 14 CD rats 
at the age of 16 and 21 months
p (age) p (diet) p (age × diet)
BW 0.048 0.837 0.508
CSA <0.001 0.006 0.448
CSA/BW <0.001 0.023 0.156
T2muscle 0.009 0.016 0.670
T2lean muscle <0.001 <0.001 0.903
Lipid fraction 0.013 0.359 0.969
 p = p value (ANOVA).
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 Discussion 
 In the present study, age- and diet-induced changes 
were investigated in quadriceps muscles because of their 
prevalence of type 2 muscle fibers which are particularly 
sensitive to aging effects  [24] . While the quadriceps mus-
cle can be easily delineated in the current animal model, 
further differentiation of single muscles is difficult based 
on MRI at 1.5 T. The maximum CSA turned out to be a 
reliable measure of morphological muscle change as 
long as the image orientation was actually perpendicular 
to the femur. This requirement could be accomplished 
in all animals for both hind limbs. Another parameter, 
CSA/BW, was introduced because of marked interindi-
vidual variations of BW in both dietary groups as well as 
in the whole collective before allocation. The CSA of the 
quadriceps muscle is expected to be – at least to some 
extent – related and influenced by BW because a larger 
muscle mass is necessary to carry a larger weight.
 CSA and CSA/BW were smaller in 16- and 21-month-
old HFD rats than in age-matched CD rats (which served 
as controls with normal diet). Similar results have been 
reported recently for the muscle volume in a pilot study 
with Wistar rats  [8] . Besides those morphological chang-
es in HFD rats we also found a prolongation of T2 relax-
ation time in the quadriceps muscle. Due to longer T2 of 
fat compared with muscle, an increase of fatty tissue with-
in the muscle is most probably one reason for increased 
T2 values of the muscle; a good correlation between both 
quantities has been described earlier for healthy  [12, 25] 
and diseased muscle tissue  [25] . However, additional ef-
fects are necessary to fully explain prolonged muscle T2 
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 Fig. 5. Boxplots summarizing the longitudinal development in 
8 HFD and 14 CD rats at the age of 16 and 21 months.  a BW of 
the animals.  b CSA of the quadriceps muscle.  c CSA/BW.  d T2 re-
laxation time across the whole CSA of the quadriceps muscle 
(T2 muscle ).  e T2 relaxation time of the lean quadriceps muscle 
(T2 lean muscle ) in a region without visible fat.  f Lipid fraction, based 
on  1 H single voxel spectroscopy. Statistical results evaluating the 
influence of age and diet are presented in  table 2 . 
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in HFD versus CD rats and with increasing age. Besides 
changes in fat content, changes in water composition 
have to be taken into account. Hatakenaka et al.  [21] re-
ported significantly increased extracellular space (relative 
to intracellular space) in type 2 muscles of old versus 
young mice based on histological analysis. While our re-
sults of muscle T2 in 16- and 21-month-old rats revealed 
a significant dependence on age and diet, the lipid content 
showed an age-related effect but no significant diet-in-
duced effect ( table 2 ). Elevated IMCL has been observed 
also in obese humans  [18, 23] and in animal studies with 
rats undergoing HFD with and without impaired insulin 
sensitivity  [13, 26–28] . Using a whole-body clinical 
1.5-tesla scanner for our animal study we were not able to 
separate IMCL and extramyocellular lipid (EMCL) in the 
quadriceps muscle of the rat. The ability to separate both 
peaks depends not only on B 0 but also on the voxel size, 
on the muscle type and on the orientation of its fibers 
relative to B 0  [16, 17] . IMCL and EMCL have been re-
ported to be well resolvable in human tibialis anterior 
muscles at 1.5 or 3 T  [22, 23] or in ventral and dorsal tib-
ialis anterior muscles of rats at 6.3 T or above  [13, 26–28] . 
Since IMCL and EMCL could not be well resolved in our 
muscle spectra, only total lipid content within the quad-
riceps muscle was evaluated in our study. However, de-
rived T2 values from different ROIs within cross-section-
al images of the hind limbs of the rats provide additional 
information. Since only very rare amounts of fatty septa 
within the musculature are visible on the images, one 
might expect that the fat fraction in T2 lean muscle is mainly 
determined by IMCL, while T2 across the whole muscle 
(T2 muscle ) also includes fatty infiltrations, i.e. EMCL and 
intermuscular adipose tissue. As diet-induced effects on 
T2 lean muscle were stronger than effects on  T2 muscle , one 
might further conclude that these effects mainly result 
from changes of homogeneously distributed material in 
the musculature (i.e. water and IMCL) rather than from 
changes in EMCL and intermuscular adipose tissue.
 Age-related changes between the ages of 16 and 21 
months revealed a decrease of CSA and CSA/BW as well 
as an increase of T2 for both diets. Reduced CSA or mus-
cle mass has been reported in older versus younger hu-
man cohorts  [19, 20, 29] . A relevant increase of muscle T2 
with advancing age has been described for human  [12, 21] 
and animal  [21] musculature, whereas no significant dif-
ferences were found for 4- versus 20-month-old rats in 
another study  [30] . Increasing lipid content with age in 
our study is consistent with prior human  [12, 22] and 
animal  [26, 31] studies on the one hand and with increas-
ing muscle T2 in the current study on the other hand.
 Analysis of age- and diet-induced changes and focus-
ing on detailed results of 16- and 21-month-old HFD and 
CD rats yields another interesting effect: nearly all mea-
surement results are very similar for 16-month-old HFD 
and 21-month-old CD rats (see  fig. 5 ). Thus, one might 
speculate that HFD induces ‘accelerated muscle aging’ in 
our animal model.
 HFD does not inevitably lead to increased BW but 
should probably be regarded as a risk factor that mere-
ly increases the probability of abnormal body fat accu-
mulation and obesity. On the other hand, CD does not 
automatically mean that all individual subjects remain 
lean with advancing age. This problem has not been 
sufficiently addressed in the literature yet in a rodent 
model. Therefore, we developed a stringent procedure 
for stratification of higher BW based on AUC analysis 
of the longitudinal weight gain. The results in the sub-
groups of heavier and normal-weight HFD and CD 
rats at the age of 16 months revealed that muscle quan-
tity and quality are affected by both HFD and higher 
BW. Interestingly, higher BW alone did not cause a 
reduction of CSA in 16-month-old rats, but rather 
points to a BW-independent ‘intrinsic’ effect of the 
HFD.
 As a very early work with an animal model for sarco-
penia, our study has several limitations. First, using a clin-
ical whole-body scanner resulted in some technical draw-
backs for the current animal model when compared with 
dedicated animal MR systems – one limitation can be 
seen in separating IMCL and EMCL signal contributions 
in  1 H-MRS. Assessment of T2 relaxation times in lean 
muscle and across the whole muscle was applied as a 
workaround in our study. Furthermore, the reason for 
prolonged muscle T2 under HFD and with advancing age 
needs additional investigation which might be based on 
imaging and/or histological examination. Second, the 
current study started with 16-month-old rats following a 
10-month-long diet without taking into account earlier 
data of the animals. Assessment of baseline data would be 
necessary to exclude any bias. Third, some other, proba-
bly influencing, factors need to be considered in further 
studies. The physical activity of the animals has to be 
monitored and the influence of intensified or hindered 
activity might yield additional aspects. Gender is another 
important factor which has to be included in further stud-
ies because fat distribution is known to be significantly 
different in men and women  [32] . It should be mentioned 
here that sarcopenia could be induced in a prior study in 
a transgenic mouse model in male, but not in female, mice 
 [33] .
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 In conclusion, this study strongly supports the hy-
pothesis that HFD has a significant impact on quadri-
ceps muscle quantity and quality in an animal model 
with male Sprague-Dawley rats. The main effects of 
HFD were a reduction of CSA and an increase in T2 re-
laxation time, which can be partially attributed to an 
increased fat content (predominantly IMCL) within the 
muscle. Both effects could be measured already at the 
age of 16 months and deteriorated with advancing age 
until the end point of the study (21 months) in HFD and 
CD rats. This study might contribute to a better under-
standing of the pathogenesis of sarcopenia and might 
allow direct translation into the clinical geriatric set-
ting.
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